IN ORGANISMO

USPTO USPTO 2002 ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke IN ORGANISMO wurde als Wortmarke am 24.01.2002 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE".

Markendetails Letztes Update: 19. Mai 2018

Markenform Wortmarke
Aktenzeichen 76362288
Anmeldedatum 24. Januar 2002

Markeninhaber

Falkenried 88
20251 Hamburg
DE

Markenvertreter

Waren und Dienstleistungen

1 DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE; DIAGNOSTIC PREPARATIONS, NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES, AND ANTIBODIES, AND MOLECULAR ARRAYS OF BIOLOGICAL MATERIALS FOR SCIENTIFIC OF RESEARCH USE
5 PHARMACEUTICAL PREPARATIONS FOR USE IN THE DIAGNOSIS AND TREATMENT OF HUMAN DISEASES AND DISORDERS, NAMELY, CIRCULATORY, RESPIRATORY, ENDOCRINE, NEUROLOGIC, CARDIOVASCULAR, ALIMENTARY, ONCOLOGIC, AUTO-IMMUNE OR IMMUNE-RELATED, PULMONARY, MUSCULOSKELETAL, LYMPHATIC, GASTROINTESTINAL, BONE, SENSORY, VIRAL, URINARY, RENAL, INFECTIOUS, METABOLIC AND CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS; DIAGNOSTIC ASSAYS AND TEST KITS COMPRISED OF REAGENTS FOR CLINICAL AND MEDICAL LABORATORY USE TO DIAGNOSE, PROGNOSE, PREDICT AND TREAT DISEASES AND FOR PROVIDING GENOMIC AND PROTEOMIC PROFILES USEFUL IN THE SELECTION OF THERAPEUTICS; ASSAYS AND TEST KITS COMPRISED OF REAGENTS FOR EVALUATING EFFICACY OF TREATMENTS AND TREATMENT PROGRESS; PROGNOSTIC TEST KITS COMPRISED OF REAGENTS FOR IDENTIFYING HEREDITARY RISK FACTORS; DIAGNOSTIC PREPARATIONS, NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES, AND ANTIBODIES, AND MOLECULAR ARRAYS OF BIOLOGICAL MATERIALS FOR CLINICAL OR MEDICAL LABORATORY USE; DIAGNOSTIC PREPARATIONS FOR CLINICAL OR MEDICAL LABORATORY USE
42 RESEARCH AND DEVELOPMENT SERVICES RENDERED TO OTHERS FOR DISCOVERING SMALL-MOLECULE DRUGS, ANTIBODIES, ANTISENSE DRUGS, PEPTIDES, PROTEINS AND GENE THERAPY DRUGS; MEDICAL AND DIAGNOSTIC SERVICES, NAMELY, DIAGNOSING, PREVENTING, AND PREDICTING DISEASE, IDENTIFYING HEREDITARY RISK FACTORS, DIAGNOSTIC TESTING, PROGNOSTIC TESTING, GENE AND PROTEIN TESTING, IDENTIFYING PHYSILOGICAL CHARACTERISTICS, ESTABLISHING INDIVIDUAL PREVENTATIVE PROGRAMS, ESTABLISHING DISEASE TREATMENTS BASED ON GENE AND PROTEIN EXPRESSION AND ACTIVITY, EVALUATING CLINICAL TRIAL PROGRESS, DRUG MONITORING AND COMPUTER TRACKING OF A PATIENT'S HEALTH PROGRESS
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1376362288